» Authors » Abdallah Alami

Abdallah Alami

Explore the profile of Abdallah Alami including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 54
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alami A, Dave S, Ebrahim M, Zareef I, Uhlik C, Laroche J
Vaccines (Basel) . 2025 Feb; 13(2). PMID: 40006679
Globally and in Canada, Indigenous populations have faced heightened vulnerability during pandemics, with historical inequities exacerbated by multigenerational colonial policies. This study aimed to identify parental factors influencing COVID-19 vaccination...
2.
Alami A, Dave S, Uhlik C, Ebrahim M, Krewski D, Laroche J
Front Public Health . 2024 Jun; 12:1400782. PMID: 38903582
Background: To identify determinants influencing Canadian parents' decision not to vaccinate their children aged 6 months to 17 years against seasonal influenza. Methods: Data from the 2022 Childhood COVID-19 Immunization...
3.
Alami A, Villeneuve P, Farrell P, Mattison D, Farhat N, Haddad N, et al.
J Clin Med . 2023 Aug; 12(15). PMID: 37568373
Concerns remain regarding the rare cardiovascular adverse events, myocarditis and pericarditis (myo/pericarditis), particularly in younger individuals following mRNA COVID-19 vaccination. Our study aimed to comprehensively assess potential safety signals related...
4.
Terrell R, Alami A, Krewski D
Int J Environ Res Public Health . 2023 Jun; 20(12). PMID: 37372669
Vaccines effectively protect against COVID-19, but vaccine hesitancy and refusal hinder vaccination rates. This systematic review aimed to (1) review and describe current interventions for addressing COVID-19 vaccine hesitancy/refusal and...
5.
Alami A, Krewski D, Farhat N, Mattison D, Wilson K, Gravel C, et al.
BMJ Open . 2023 Jun; 13(6):e065687. PMID: 37339840
Objective: To summarise the available evidence on the risk of myocarditis and/or pericarditis following mRNA COVID-19 vaccination, compared with the risk among unvaccinated individuals in the absence of COVID-19 infection....
6.
Otero-Losada M, Petrovsky N, Alami A, Crispo J, Mattison D, Capani F, et al.
Expert Opin Drug Saf . 2022 Aug; 22(4):343-349. PMID: 36043937
Background: Information on neurological and psychiatric adverse events following immunization (AEFIs) with COVID-19 vaccines is limited. Research Design & Methods: We examined and compared neurological and psychiatric AEFIS reports related...
7.
Moore T, Alami A, Alexander G, Mattison D
Pharmacotherapy . 2022 Jun; 42(7):567-579. PMID: 35665948
Ketamine, an anesthetic available since 1970, and esketamine, its newer S-enantiomer, provide a novel approach for the treatment of depression and other psychiatric disorders. At subanesthetic doses, the two drugs,...
8.
Alami A, Krewski D, Mattison D, Wilson K, Gravel C, Villeneuve P, et al.
Vaccines (Basel) . 2022 May; 10(5). PMID: 35632478
There have been reports of cases of myocarditis and pericarditis as rare complications following mRNA COVID-19 vaccinations among young adults. While most reported cases are mild, this potential vaccine safety...
9.
Taher M, Alami A, Gravel C, Tsui D, Bjerre L, Momoli F, et al.
Expert Opin Drug Saf . 2021 Oct; 21(2):269-276. PMID: 34641748
Background: Quinolones comprise a class of antibiotics that are globally preferred for treating a wide range of bacterial infections due to their potency, broad coverage, favorable pharmacologic profile, and mostly...
10.
Taher M, Alami A, Gravel C, Tsui D, Bjerre L, Momoli F, et al.
JGH Open . 2021 Jul; 5(7):778-784. PMID: 34263072
Background And Aim: Quinolones are a potent and globally popular group of antibiotics that are used to treat a wide range of infections. Some case reports have raised concern about...